Matteo Trotta's most recent trade in Incyte Corp. was a trade of 537 Common Stock done at an average price of $62.1 . Disclosure was reported to the exchange on March 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Incyte | Matteo Trotta | EVP, GM, Dermatology US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 25 Mar 2025 | 537 | 9,937 (0%) | 0% | 62.1 | 33,337 | Common Stock |
| Incyte | Matteo Trotta | EVP, GM, Dermatology US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 5,371 | 5,371 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Matteo Trotta | EVP, GM, Dermatology US | 15 Jul 2024 | 5,921 | 5,921 | - | - | Employee Stock Option (right to buy) | ||
| Incyte | Matteo Trotta | EVP, GM, Dermatology US | 15 Jul 2024 | 2,646 | 10,474 (0%) | 0% | 0 | Common Stock | ||
| Incyte | Matteo Trotta | EVP, GM, Dermatology US | 25 Mar 2024 | 21,868 | 21,868 | - | - | Employee Stock Option (right to buy) | ||
| Incyte | Matteo Trotta | EVP, GM, Dermatology US | 25 Mar 2024 | 7,828 | 7,828 (0%) | 0% | 0 | Common Stock |